| Ytd | 10.84% | |
| 1y | 151.00% |
| Open | 25.64 | Prev Close | 25.09 | Low | 24.72 | High | 25.64 | Mkt Cap | 187.31M |
| Vol | 140.41K | Avg Vol | 179.90K | EPS | -23.99 | P/E | -1.04 | Forward P/E | -2.75 |
| Beta | 0.52 | Short Ratio | 0.97 | Inst. Own | 77.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-09 | 50-d Avg | 22.93 | 200-d Avg | 23.09 | 1yr Est | 33.00 |
SRZN News
Planned IND submission for SZN-8141 in diabetic macular edema by the end of the third quarter of 202
Surrozen NASDAQ: SRZN Chief Executive Officer Craig Parker outlined the company's rationale for deve
SOUTH SAN FRANCISCO, Calif. , July 15, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. ("Surrozen" or the "C
SOUTH SAN FRANCISCO, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Com
On track to submit an Investigational New Drug application for SZN-8141 to FDA in the second half of
SOUTH SAN FRANCISCO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “C
Surrozen (NASDAQ: SRZN - Get Free Report) and MediWound (NASDAQ: MDWD - Get Free Report) are both sm
Surrozen (SRZN) saw its shares surge in the last session with trading volume being higher than avera
Surrozen, Inc. (NASDAQ: SRZN - Get Free Report) major shareholder Tcg Crossover Gp Ii, Llc acquired
Expect to submit an Investigational New Drug application for SZN-8141 to FDA in the second half of 2
Surrozen, Inc. (NASDAQ: SRZN - Get Free Report) major shareholder Tcg Crossover Gp Ii, Llc acquired
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Co
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Co
Surrozen (NASDAQ: SRZN - Get Free Report) and Galmed Pharmaceuticals (NASDAQ: GLMD - Get Free Report
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Co
Surrozen, Inc. (NASDAQ: SRZN - Get Free Report) major shareholder Group Gp Lp Column III bought 18,0
Surrozen, Inc. (NASDAQ: SRZN - Get Free Report) major shareholder Group Gp Lp Column III purchased 1
Surrozen, Inc. (NASDAQ: SRZN - Get Free Report) Director Tim Kutzkey purchased 11,893 shares of Surr
Surrozen, Inc. (NASDAQ: SRZN - Get Free Report) Director Tim Kutzkey purchased 18,052 shares of the
Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earni
On Wednesday, 340 stocks hit new 52-week lows.
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Sc
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) rose 148% to $3.78. Sunshine Biopharma, last mont
Gainers